CSL Behring therapies are indicated for the treatment of
coagulation disorders including haemophilia and von Willebrand disease, primary immune deficiencies, hereditary angioedema and inherited respiratory disease.
A CVC was scheduled in 15 patients with a
coagulation disorder (platelet count under 50000 /[micro]l and/or International Normalised Ratio >1.
Deficiencies in other coagulation proteins including factors V, VII, X, and XI are considered rare inherited
coagulation disorders (RICD) and are transmitted as autosomal recessive traits in both sexes, with a frequency shown as homozygous forms in the general population (Table 1).
Failure to recognize an uncommon acquired
coagulation disorder can have serious consequences.
In 199 of the 201 patients, we determined that the bleeding had not been related to a
coagulation disorder.
The presence or absence of comorbid conditions, such as an acute illness, pregnancy, or the treatment of a
coagulation disorder before the final diagnosis is established, can interfere with results of coagulation testing to the extent that correct diagnosis may not be achieved even with appropriate test selection.
There is a clear need for a new generation of protein engineering companies, and Eleven's drug programs are uniquely positioned to address unmet needs for a range of diseases, such as inflammatory conditions and
coagulation disorders," said Mark Levin, interim chief executive officer and board member of Eleven Biotherapeutics, and partner, Third Rock Ventures.
com/research/a4f4b9/haemophilia_and_bl) has announced the addition of the "Haemophilia and Blood
Coagulation Disorders Therapy Area Pipeline Report" report to their offering.
Represent people who use plasma protein therapies to treat
coagulation disorders, immune deficiencies, genetic emphysema or other conditions; and
The mission ofHFM is: "The Hemophilia Foundation of Michigan strives to improve the quality of life for all people affected by hemophilia, von Willebrand disease, other
coagulation disorders, and related complications, including HIV/AIDS and hepatitis.
In addition to funding organizations that assist people with pulmonary disorders, CSL Behring also provides funding to organizations that support patients with
coagulation disorders.
In keeping with our mission to advance the understanding and science of
coagulation disorders, CSL Behring proudly supports the outstanding research projects proposed by these young clinicians," said Val Romberg, Head of Research and Development at CSL Behring.
